Arterial hypertension from the adrenal gland: Prognosis and predictive factors of recovery after chirurgical treatment

2018 ◽  
Author(s):  
Ibtissem Oueslati ◽  
Amel Melki ◽  
Melika Chihaoui ◽  
Meriem Yazidi ◽  
Fatma Chaker ◽  
...  
2016 ◽  
Vol 3 (3) ◽  
pp. 255-264
Author(s):  
Elis Martins Ulbrich ◽  
Maria de Fátima Mantovani ◽  
Ângela Taís Mattei ◽  
Leila Maria Mansano Sarquis ◽  
Juliana Perez Arthur ◽  
...  

2018 ◽  
Vol 69 (9) ◽  
pp. 2425-2429
Author(s):  
Carmen Gadau ◽  
Elena Ardeleanu ◽  
Roxana Folescu ◽  
Ioan Tilea ◽  
Andreea Varga ◽  
...  

The present cross-sectional observational study was made in family medicine offices of Timi� County, Romania. The aim of the study was to investigate the prevalence of urinary microalbumin excretion (MAU) in resistant systemic arterial hypertension (RH), to analyze patients� biochemical and clinical characteristics, and the predictive factors for MAU. From a total number of 347 patients, MAU was detected in 76 cases (21.9%). The microalbuminuria positive patients were older, with significant higher office systolic blood pressure (BP) (155 � 13.50 vs 148 � 12.40 mmHg, p [ 0.0001) and diastolic blood pressure (94 � 12.20 vs 88 � 14.6 mmHg, p = 0.0013), higher prevalence of left ventricular hypertrophy, diabetes mellitus, obesity, ischemic and peripheral arterial disease. MAU positive patients presented statistical significant differences in biochemical data concerning: fasting plasma glucose (FPG) (118.80 � 32.02 vs 108.01 � 26.01 mg/dL, p = 0.003), impaired glucose tolerance (IGT) (10.52 % vs 4.94 %), glycated hemoglobin (HbA1c) (6.56 � 0.98% vs 5.96 � 0.91%, p [ 0.001), reduced estimated glomerular filtration rate (eGFR) (56.10 � 15.4 vs 69.30 � 17.5 ml/min/1.73m2, p [ 0.001) and higher potassium levels (4.71 � 0.43 vs 4.59 � 0.44 mg/dL, p = 0.0378). No significant differences were noticed regarding LDL- and HDL-cholesterol, triglycerides, uric acid and serum creatinine. In a logistic multivariate analysis independent predictors for MAU were: systolic BP (odds ratio, OR = 1.024, 95% confidence interval, CI:1.011-1.039, p [ 0.001), HbA1c (OR = 1.324, 95% CI: 1.078-1.724, p = 0.008) and eGFR (OR = 0.989, 95% CI: 0.977-0.999, p = 0.01). Our findings suggest that an important part of RH patients have microalbuminuria and highlight the importance of controlling its predictors, in order to improve patients� outcome.


2012 ◽  
Vol 108 (12) ◽  
pp. 1049-1060 ◽  
Author(s):  
Mardi Gomberg-Maitland ◽  
Adaani Frost ◽  
Robert Frantz ◽  
Marc Humbert ◽  
Michael McGoon ◽  
...  

SummaryPulmonary arterial hypertension (PAH) is characterised by increased pressure in the pulmonary arteries leading to right-sided ventricular failure, and death. Identification of factors that affect patient survival is important to improve patient management and outcomes. The first registry to evaluate survival and develop a prognostic model was the National Institutes of Health (NIH) registry in 1981. Importantly this prognostic model is based on data collected prior to availability of PAH-targeted therapies and does not reflect survival rates for treated patients. Since the 1980s, however, four modern registries of PAH now exist which compensate for the NIH equations shortcomings and include the French National registry, Pulmonary Hypertension Connection registry, the Mayo registry, and the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). The similarities and difference in these registries are highlighted in this review and although similar in many respects, the four registries vary in patient population, including the numbers of newly and previously diagnosed patients, as well as the era of observation, period of survival, and timing of assessment of potential predictive factors. Despite this, the predictive factors identified in each registry and described in detail within the body of this manuscript share surprising homology in that disease aetiology, patient gender and factors reflective of right heart failure are integral in depicting survival. Future modifications of modern prognostic equations should be an ongoing goal of the PAH community in order to provide increased accuracy with identification of novel risk factors and prediction of disease course.


2022 ◽  
pp. 030098582110710
Author(s):  
Marta Mainenti ◽  
Arnaud J. Van Wettere

Spontaneous migration of placental trophoblasts into maternal blood vessels and embolization to other organs (ie, lung, adrenal gland, spleen, and liver) occurs in women and certain animals with hemochorial placentation. Although considered incidental in most species, increased incidence and numbers of trophoblast emboli are reported in women with gestational diseases with arterial hypertension (pre-eclampsia and eclampsia). To the best of our knowledge, trophoblast emboli have not been reported in lagomorphs. This case report describes the identification of trophoblast emboli in the lung of a wild snowshoe hare ( Lepus americanus). Death of this hare was attributed to pulmonary hemorrhages and hemothorax, but a definitive cause for the hemorrhages was not determined. It is unclear whether trophoblast embolism normally occurs in this species and represents an incidental finding, or whether it possibly contributed to rupture of pulmonary or thoracic blood vessels leading to hemorrhage.


2011 ◽  
Vol 29 ◽  
pp. e513
Author(s):  
O. Belichenko ◽  
A. Smolenskiy ◽  
A. Vorontsov ◽  
V. Vladimirova ◽  
E. Averkieva ◽  
...  

1986 ◽  
Vol 67 (1) ◽  
pp. 36-40
Author(s):  
Ya. Yu. Malkov ◽  
O. E. Karpova

Pheochromocytoma is a catecholamine-producing tumour that arises from the medullary layer of the adrenal gland or extrarenal chromaffin tissue and is not uncommon. An analysis of sectional data published in the world literature in the last two decades shows that pheochromocytoma in 1% of cases; is the cause of hypertension, which in 50-60% of patients runs as a paroxysmal form of arterial hypertension and can progress to a permanent form with or without crises.


Sign in / Sign up

Export Citation Format

Share Document